A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'Is cerebrospinal fluid (CSF) drainage of benefit in patients undergoing surgery on the descending thoracic aorta or thoracoabdominal aorta?' Altogether 1177 papers were found using the reported search, of which 17 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Ten of 13 studies demonstrate significant neurological protection from CSF drainage (±additional adjuncts), with two further papers showing no significant difference between patients who had or had not had CSF drainage and one study unable to provide any conclusions. For patients having surgery on the thoracic aorta or thoracoabdominal aorta CSF drainage, maintaining pressures <10 mmHg (P < 0.03), in conjunction with other neuroprotective strategies, minimizes the risk of neurological sequelae when compared with patients treated with similar adjuncts but without CSF drainage. The majority of studies used additional neuroprotective strategies, including cooling and reattachment of the intercostal arteries as adjuncts to CSF drainage. Logistic regression curves demonstrated that the longer the ischaemia time, the greater the benefit from CSF drainage (P < 0.04). Four papers observed complications of CSF drainage, of which the main complications were: catheter occlusion or dislodgement, headache, meningitis and subdural haematoma. Overall, CSF drainage does offer a neuroprotective benefit; preventing paraplegia if CSF pressures are maintained <10 mmHg.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] . 
THREE-PART QUESTION

CLINICAL SCENARIO
You have a 63-year old patient listed for repair of an extensive aneurysm to the descending thoracic and thoracoabdominal aorta. You wonder whether to use cerebrospinal fluid (CSF) drainage in this patient. 
SEARCH STRATEGY
An
SEARCH OUTCOME
The search returned 1177 papers. From these, 21 papers were identified as answering our question. Duplicated and nonrandomized studies containing fewer than 40 patients who had undergone CSF drainage were removed. Seventeen papers provided the best evidence to answer the question: These are presented in Table 1 . Meta-analysis (level 1a)
Fourteen studies were identified that used CSF drainage (CSFDr) of patients undergoing elective or emergent surgery to treat dissecting and nondissecting TAAs and TAAAs
Three were RCTs (n = 289), five cohort studies with a control group, and six were cohort studies without a control group Paraplegia (randomized and non-randomized studies with a control group) OR 0.30 in patients undergoing CSFDr (95% CI 0.17-0.54, P = 0.0001). ARR = 9% (95% CI 5-13%, P = 0.0001). NNT = 11 (95% CI [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] A number of small, poorer quality studies were included in the meta-analysis. Authors concluded that CSF drainage should be used in high-risk TAAA and dissection patients, although further research is required 
Spinal infection Nil
Bloody CSF Twenty-four of 482 patients. All had CT which showed: no haematoma formation in any patient but intracranial bleeding in 17 of 24 patients (3 of 17 of which had neurological deficit but were noted to have had preoperative cerebral atrophy with brain volume loss.)
Higher volume of CSF drained correlated with an increased
Continued
The two meta-analyses included the three randomized control trials (RCTs) (described below) looking at CSFDr in Type I and II TAAAs.
Cina et al.'s [2] meta-analysis, of 14 studies (including results from both TAAs and TAAAs), found a pooled odds ratio (OR) from all studies of 0.3 for postoperative paraplegia in patients undergoing CSF drainage (95% confidence interval [CI] 0.17-0.54, P = 0.0001).
Khan and Stansby's [3] meta-analysis, of the three RCTs only (all Type I or II TAAAs), reported a higher OR for postoperative paraplegia of 0.57 (95% CI 0.28-0.17) in patients undergoing CSF drainage.
Crawford et al. [4] conducted a RCT (98 patients) looking at CSF drainage (various CSF pressures) in Type I and II TAAA, and concluded that CSF drainage did not prevent paraplegia.
Svensson et al. [5] conducted a RCT (33 patients) assessing the effects of CSFDr and intrathecal papaverine (IP) (CSFDr + IP, pressures maintained <10 mmHg) compared with a control group in preventing neurological injury. Neurological injury occurred in 2 of 17 CSFDr + IP patients and 7 of 16 patients in the control (P = 0.0392). Active cooling in combination with CSFDr + IP was used in 8 patients, none of whom experienced neurological injury. The OR for neurological injury was 0.02, using CSFDr + IP (adjusted for active cooling and aortic clamp time).
Coselli et al. [6] found that CSF drainage ( pressures maintained <10 mmHg) during the intraoperative and 48 h postoperative period reduced the rate of paraplegia after repair of Type I and II TAAAs (P = 0.03). Logistic regression curves demonstrated that the longer the ischaemia time, the greater the benefit from CSF drainage (P < 0.04).
Hollier et al. [7] found a lower incidence of neurological deficit (P < 0.01) once CSF drainage was introduced as a routine protocol.
Murray et al. [8] conducted a retrospective cohort study of 99 patients undergoing descending thoracic aorta or TAAA (I, II, III) ± CSFDr. They found no significant difference in spinal deficit between the two groups.
Safi et al. [9] demonstrated a reduced risk of neurological deficit in patients with TAAA or descending TAA undergoing cross-clamp times >30 min (OR: 0.28, 95% CI 0.11-0.70, P = 0.004) if CSFDr is used with distal aortic perfusion (CSFDr + DAP). A further study from Safi et al. [10] demonstrated that CSFDr + DAP conferred the greatest benefit in high-risk Type II TAAA patients in preventing neurological deficits (NNT all cases = 23, NNT Type II TAAA = 5). Improved long-term survival was seen in CSFDr + DAP patients (P < 0.002). Estrera et al. [11] found a lower incidence of neurological deficit in CSFDr + DAP patients (2 of 238) compared with controls (4 of 62) undergoing descending TAA repairs (P < 0.02). Acher et al. [12] found that CSF drainage ( plus naloxone) was a significant factor in reducing paraplegia and paralysis post-TAAA or descending TAA surgery (P < 0.03).
Cheung et al. [13] observed an incidence of 11 with paraplegia in 99 patients who underwent CSF drainage ( pressure aim <12 mmHg) during TAAA and TAA repairs. Higher lumbar CSF pressures were demonstrated in patients with paraplegia compared with pressures when patients had recovered (P < 0.001).
Hnath et al. [14] observed an increased incidence of spinal cord ischaemia following thoracic endovascular aortic repair without (n = 65), compared with, (n = 56) CSF drainage.
Weaver et al. [15] conducted an observational study (n = 65) of complications following CSF drainage during TAAA repairs. Two of 62 patients undergoing CSF drainage developed intradural haemotomas at the site of CSF catheter insertion.
Cheung et al. [16] found that 23 of 162 patients died (14.1% mortality). Nineteen patients developed immediate or delayed paraplegia or paraparesis, which was permanent in 8 patients. They also observed temporary abducens nerve palsy, meningitis, retained catheter fragments due to catheter fracture during removal and post-lumbar puncture spinal headache. All patients recovered with no sequelae.
Wynn et al. [17] demonstrated mortality from CSF drainage of 0.6%. The most common side effect was drain failure, the rate of which declined when using a larger drain (P = 0.0054).
Leyvi et al. [18] reported higher incidences of neurological events in the CSFDr groups compared with controls.
CLINICAL BOTTOM LINE
Ten of 13 studies demonstrate significant neurological protection from CSF drainage (±additional adjuncts, two papers showed no significant difference between controls and one study was unable to provide any conclusions). In the studies that demonstrated no significant difference, CSF pressures were not infrequently >15 mmHg, and it does appear from the remaining studies that benefit is obtained through the maintenance of CSF pressures <10 mmHg. Unfortunately, many of these studies did also use an additional adjunct, which makes the analysis of the effects of CSF drainage alone harder.
Despite the observed complications (catheter occlusion or dislodgement, headache, meningitis and subdural haematoma being the most noted), CSF drainage (maintaining pressures <10 mmHg) in patients undergoing thoracic and/or thoracoabdominal aortic surgery is an effective neuroprotective adjunct.
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